United States Access Board

July 2013 — Pursuant to Section 904 of the Food and Drug Administration Safety and Innovation Act, the U.S.

June 2013 — The U.S.

October 31, 2012 —The United States Access Board has started an initiative to improve access to prescription drug labels, specifically for individuals who are blind, visually impaired or elderly, following the Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012. A working group, including representatives from industry and various blind and elderly advocacy organizations, will evaluate alternatives such as the inclusion of braille on prescription labels, auditory technology to include “talking bottles”, and radio frequency identification tags.